Balhuizen, Alexander http://orcid.org/0000-0001-7581-121X
Massa, Sam http://orcid.org/0000-0003-2896-3549
Mathijs, Iris
Turatsinze, Jean-Valery
De Vos, Jens
Demine, Stéphane http://orcid.org/0000-0002-7254-2269
Xavier, Catarina
Villate, Olatz
Millard, Isabelle
Egrise, Dominique
Capito, Carmen
Scharfmann, Raphaël
In’t Veld, Pieter
Marchetti, Piero
Muyldermans, Serge
Goldman, Serge
Lahoutte, Tony
Bouwens, Luc
Eizirik, Decio L. http://orcid.org/0000-0003-2453-5889
Devoogdt, Nick
Article History
Received: 2 June 2017
Accepted: 27 October 2017
First Online: 9 November 2017
Competing Interests
: A.B., I. Ma., S.M., L.B., N.D. and D.L.E. have submitted a patent based on the use of DPP6 and the nanobodies targeting it for pancreatic islet cell imaging. T.L., J.D. and N.D. are cofounders and consultants of the biotech company Camel-IDS. T.L. and N.D. have received funding from Boehringer-Ingelheim, Complix and 121BIO. T.L. and N.D. hold patents on Nanobody imaging and therapy.